VRDN

News Viridian (VRDN) Q2 Net Loss Widens 55%

14d ago

News 7 Analysts Assess Viridian Therapeutics: What You Need To Know

14d ago

Insider trade Purchase by Fairmount Funds Management LLC / Fairmount Healthcare Fund II GP LLC / Fairmount Healthcare Fund II L.P.

19d ago

News Viridian Therapeutics prices upsized $350M concurrent stock, and convertible notes offerings

26d ago

Scanner Large up move: 33.4% (2.7x normal daily movement)

26d ago

Scanner Large up move: 33.4% (2.8x normal daily movement)

27d ago

SEC filing VRDN Reports $0 Revenue, $0 EPS, +94% YoY Growth, Launches Elegrobart Autoinjector for Chronic TED, BLA 2027, +50% Proptosis Response

28d ago

News Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake

99d ago

News 4DMT Appoints Kristian Humer as Chief Financial Officer

156d ago

Scanner Unusual volume (z=4.0)

160d ago

Scanner Unusual volume (z=4.2)

162d ago

Scanner Unusual volume (z=4.2)

163d ago

Scanner Unusual volume (z=4.2)

164d ago